Fairhaven Wealth Management, LLC Danaher Corp Transaction History

Fairhaven Wealth Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$185.1 - $233.13 $74,410 - $93,718	-402 Reduced 11.78%	3,010 $696,000
Q3 2023 Nov 14, 2023	SELL	$233.08 - $265.59 $4,428 - $5,046	-19 Reduced 0.55%	3,412 $846,000
Q4 2022 Feb 10, 2023	SELL	$241.42 - $282.29 $72,908 - $85,251	-302 Reduced 8.09%	3,431 $910,000
Q3 2022 Nov 10, 2022	SELL	$247.06 - $1507.4 $2,470 - $15,074	-10 Reduced 0.27%	3,733 $964,000
Q2 2022 Aug 08, 2022	BUY	$237.11 - $299.66 $4,030 - $5,094	17 Added 0.46%	3,743 $949,000
Q2 2021 Aug 09, 2021	SELL	$225.08 - $271.69 $3,376 - $4,075	-15 Reduced 0.4%	3,726 $1 Million
Q1 2021 May 13, 2021	BUY	$212.38 - $245.9 $3,185 - $3,688	15 Added 0.4%	3,741 $842,000
Q2 2020 Aug 14, 2020	BUY	$128.7 - $176.83 $13,642 - $18,743	106 Added 2.93%	3,726 $659,000
Q1 2020 May 05, 2020	BUY	$121.39 - $169.05 $4,734 - $6,592	39 Added 1.09%	3,620 $501,000
Q4 2018 Feb 14, 2019	BUY	$94.85 - $109.54 $339,657 - $392,262	3,581 New	3,581 $369,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Fairhaven Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fairhaven Wealth Management, LLC with notifications on news.